Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 15, Issue 7, Pages 645-652
Publisher
Informa UK Limited
Online
2017-06-28
DOI
10.1080/14787210.2017.1348894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Outcomes of Extended Versus Intermittent Infusion of Piperacillin/Tazobactam in Critically Ill Patients: A Prospective Clinical Trial
- (2017) Sheung-Yin Fan et al. PHARMACOTHERAPY
- Outcomes of an extended-infusion piperacillin-tazobactam protocol implementation in a community teaching hospital adult intensive care unit
- (2016) P. M. Schmees et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials
- (2016) Jason A. Roberts et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
- (2016) Mohd H. Abdul-Aziz et al. INTENSIVE CARE MEDICINE
- What’s new in multidrug-resistant pathogens in the ICU?
- (2016) Gabor Zilahi et al. Annals of Intensive Care
- A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis
- (2015) Joel M. Dulhunty et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
- (2015) Mohd H. Abdul-Aziz et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis
- (2015) Marcella Alsan et al. LANCET INFECTIOUS DISEASES
- The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-ResistantEnterobacterOsteomyelitis
- (2015) Adam Stewart et al. Microbial Drug Resistance
- Mechanisms of antimicrobial resistance in Gram-negative bacilli
- (2015) Étienne Ruppé et al. Annals of Intensive Care
- Extended-Infusion versus Standard-Infusion Piperacillin-Tazobactam for Sepsis Syndromes at a Tertiary Medical Center
- (2014) Scott R. Cutro et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
- (2014) J. A. Roberts et al. CLINICAL INFECTIOUS DISEASES
- Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort
- (2014) R. Leistner et al. INFECTION
- Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients
- (2014) Jan J. De Waele et al. INTENSIVE CARE MEDICINE
- Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: a meta-analysis
- (2014) Jocelyn Teo et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Prolonged vs intermittent infusion of piperacillin/tazobactam in critically ill patients: A narrative and systematic review
- (2014) Erlangga Yusuf et al. JOURNAL OF CRITICAL CARE
- Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection
- (2014) Shawn H. MacVane et al. Journal of Hospital Medicine
- Extended-Infusion Cefepime Reduces Mortality in Patients with Pseudomonas aeruginosa Infections
- (2013) Karri A. Bauer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Protein Binding of β-Lactam Antibiotics in Critically Ill Patients: Can We Successfully Predict Unbound Concentrations?
- (2013) Gloria Wong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009–2011)
- (2013) Helio S. Sader et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic
- (2012) Jason A Roberts et al. BMC INFECTIOUS DISEASES
- Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
- (2012) J. M. Dulhunty et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
- (2012) Dawn M. Sievert et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
- (2012) Fekade Sime et al. Annals of Intensive Care
- Rationale and evidence for extended infusion of piperacillin-tazobactam
- (2011) S. E. Kaufman et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials
- (2011) Pranita D Tamma et al. BMC INFECTIOUS DISEASES
- Trends in antimicrobial resistance in intensive care units in the United States
- (2011) Kavitha Prabaker et al. Current Opinion in Critical Care
- Revisiting Beta-lactams – PK/PD improves dosing of old antibiotics
- (2011) Alasdair MacGowan CURRENT OPINION IN PHARMACOLOGY
- Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa
- (2011) Souha S. Kanj et al. MAYO CLINIC PROCEEDINGS
- The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) Study: A Multicenter Study
- (2011) Raymond J Yost et al. PHARMACOTHERAPY
- Importance of Infusion Volume and Pump Characteristics in Extended Administration of -Lactam Antibiotics
- (2010) B. Claus et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department*
- (2010) David F. Gaieski et al. CRITICAL CARE MEDICINE
- Multiresistant Gram-negative infections: a global perspective
- (2010) Jennifer Ho et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins
- (2010) M. E. A. de Kraker et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Stability of meropenem and doripenem solutions for administration by continuous infusion
- (2010) K. Berthoin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
- (2009) Anand Kumar et al. CHEST
- Bad Bugs, No Drugs: No ESCAPE Revisited
- (2009) Lance R. Peterson CLINICAL INFECTIOUS DISEASES
- A systematic review on clinical benefits of continuous administration of β-lactam antibiotics*
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- The clinical consequences of antimicrobial resistance
- (2009) Louis B Rice CURRENT OPINION IN MICROBIOLOGY
- Pathogens Resistant to Antibacterial Agents
- (2009) Luke F. Chen et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Pharmacokinetics and Pharmacodynamics of Antibacterial Agents
- (2009) Matthew E. Levison et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
- (2009) Jean-Louis Vincent JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia
- (2009) Anthony M. Nicasio et al. JOURNAL OF CRITICAL CARE
- Predictors of 30-Day Mortality and Hospital Costs in Patients With Ventilator-Associated Pneumonia Attributed to Potentially Antibiotic-Resistant Gram-Negative Bacteria
- (2008) Katherine E. Kollef et al. CHEST
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
- Clinical and economic burden of antimicrobial resistance
- (2008) Lisa L Maragakis et al. Expert Review of Anti-Infective Therapy
- Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: Characteristics and outcome in a series of 28 patients
- (2008) Matthew E. Falagas et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started